2015
DOI: 10.1681/asn.2015010067
|View full text |Cite
|
Sign up to set email alerts
|

Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization

Abstract: In patients with autosomal dominant polycystic kidney disease (ADPKD), massive renal enlargement is a serious problem. Renal transcatheter arterial embolization (TAE) can reduce renal volume (RV), but effectiveness varies widely, and the reasons remain unclear. We investigated factors affecting renal volume reduction rate (RVRR) after renal TAE in all 449 patients with ADPKD who received renal TAE at Toranomon Hospital from January of 2006 to July of 2013, including 228 men and 221 women (mean age =57.069.1 ye… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
19
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 60 publications
2
19
0
Order By: Relevance
“…When renal transcatheter arterial embolization (TAE) is performed, coils are employed to obstruct blood flow in the main renal arteries, resulting in ischemia and kidney shrinkage [11]. For hepatic TAE, coils are placed in certain hepatic artery branches to obstruct blood flow to the regions occupied by cysts, resulting in shrinkage of the hepatic cysts [12].…”
Section: Renal or Hepatic Transcatheter Arterial Embolizationmentioning
confidence: 99%
“…When renal transcatheter arterial embolization (TAE) is performed, coils are employed to obstruct blood flow in the main renal arteries, resulting in ischemia and kidney shrinkage [11]. For hepatic TAE, coils are placed in certain hepatic artery branches to obstruct blood flow to the regions occupied by cysts, resulting in shrinkage of the hepatic cysts [12].…”
Section: Renal or Hepatic Transcatheter Arterial Embolizationmentioning
confidence: 99%
“…For massive enlarged kidney or liver, we perform renal or hepatic transcatheter arterial embolization (TAE). The total kidney volume decreases by about 45% on average at 1 year after renal TAE [ 10 ], while the liver volume decreases by about 9.2% on average [ 11 ]. The effectiveness of hepatic TAE is limited, which is why markedly fewer patients receive hepatic TAE than renal TAE.…”
Section: Introductionmentioning
confidence: 99%
“…Renal transcatheter arterial embolization (TAE) also can reduce kidney volume, and many ADPKD patients undergoing hemodialysis have received TAE treatment. Suwabe et al reported renal volume reduction rate by TAE treatment ranged from 3.9 to 84.8% [2]. She strongly complained to remove the left kidney completely because of distress.…”
Section: Discussionmentioning
confidence: 97%